Inspire Medical Systems, Inc.

NYSE:INSP Voorraadrapport

Marktkapitalisatie: US$5.2b

Inspire Medical Systems Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Inspire Medical Systems heeft een totaal eigen vermogen van $696.6M en een totale schuld van $0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk $796.2M en $99.6M. De EBIT Inspire Medical Systems is $13.5M waardoor de rentedekking -0.6 is. Het heeft contanten en kortetermijnbeleggingen van $411.0M.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

US$0

Schuld

Rente dekkingsratio-0.6x
ContantUS$410.99m
AandelenUS$696.56m
Totaal verplichtingenUS$99.63m
Totaal activaUS$796.19m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Inspire Medical Systems, Inc. Just Recorded A 894% EPS Beat: Here's What Analysts Are Forecasting Next

Nov 07
Inspire Medical Systems, Inc. Just Recorded A 894% EPS Beat: Here's What Analysts Are Forecasting Next

A Look At The Intrinsic Value Of Inspire Medical Systems, Inc. (NYSE:INSP)

Oct 31
A Look At The Intrinsic Value Of Inspire Medical Systems, Inc. (NYSE:INSP)

Is Now The Time To Look At Buying Inspire Medical Systems, Inc. (NYSE:INSP)?

Oct 03
Is Now The Time To Look At Buying Inspire Medical Systems, Inc. (NYSE:INSP)?

After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar

Aug 08
After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar

Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?

Jul 17
Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?

At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?

Jun 22
At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?

Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors

May 09
Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors

Inspire Medical Systems: A Potential Example Of Market Mispricing

Apr 05

Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Mar 27
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Mar 06
Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical: A Good Night Sleep

Feb 08

Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors

Dec 26
Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors

Inspire Medical Systems: Time To Wake Up

Nov 17

An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued

Nov 13
An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued

Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth

Oct 25

When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?

Sep 05
When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical Systems: Excellent Execution And Reset Valuation

Aug 17

Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?

Aug 10
Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?

Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment

Jul 19

Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing

Jul 16
Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing

Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating

Jun 15

Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching

May 06
Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching

Inspire Medical stock rises after guiding revenue above estimates

Jan 09

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $582.5M ) INSP } overtreffen de korte termijn passiva ( $74.3M ).

Langlopende schulden: De kortetermijnactiva INSP ( $582.5M ) overtreffen de langetermijnschulden ( $25.4M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: INSP is schuldenvrij.

Schuld verminderen: INSP heeft geen schulden vergeleken met 5 jaar geleden, toen de schuld/eigen vermogen-ratio 16.8% was.

Schuldendekking: INSP heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.

Rentedekking: INSP heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.


Balans


Ontdek gezonde bedrijven